BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21554219)

  • 1. Physiological changes in the critically ill patient with sepsis.
    Hosein S; Udy AA; Lipman J
    Curr Pharm Biotechnol; 2011 Dec; 12(12):1991-5. PubMed ID: 21554219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy.
    Kuang D; Verbine A; Ronco C
    Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
    Landersdorfer CB; Nation RL
    Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
    Blot SI; Pea F; Lipman J
    Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
    Blot S; Lipman J; Roberts DM; Roberts JA
    Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic dose optimization in critically ill patients.
    Cotta MO; Roberts JA; Lipman J
    Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Pharmacodynamics of Antimicrobials in Critically Ill Patients.
    Owen EJ; Gibson GA; Buckman SA
    Surg Infect (Larchmt); 2018; 19(2):155-162. PubMed ID: 29272204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
    Phe K; Heil EL; Tam VH
    J Infect Dis; 2020 Jul; 222(Suppl 2):S132-S141. PubMed ID: 32691832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.
    Heffernan AJ; Mohd Sazlly Lim S; Lipman J; Roberts JA
    Anaesth Crit Care Pain Med; 2021 Dec; 40(6):100970. PubMed ID: 34728411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
    Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICU nephrology: the implications of cardiovascular alterations in the acutely ill.
    Vincent JL; De Backer D
    Kidney Int; 2012 Jun; 81(11):1060-6. PubMed ID: 22113527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D deficiency in critically ill children with sepsis.
    Ponnarmeni S; Kumar Angurana S; Singhi S; Bansal A; Dayal D; Kaur R; Patial A; Verma Attri S
    Paediatr Int Child Health; 2016 Feb; 36(1):15-21. PubMed ID: 26120004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients.
    Muckart DJ; Bhagwanjee S
    Crit Care Med; 1997 Nov; 25(11):1789-95. PubMed ID: 9366759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adequate anti-infective treatment : Importance of individual dosing and application].
    Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
    Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study.
    Schlapbach LJ; Straney L; Alexander J; MacLaren G; Festa M; Schibler A; Slater A;
    Lancet Infect Dis; 2015 Jan; 15(1):46-54. PubMed ID: 25471555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pharmacokinetics of antimicrobial agents in critically ill patients.
    Pea F
    Curr Clin Pharmacol; 2013 Feb; 8(1):5-12. PubMed ID: 22946868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic dosing in multiple organ dysfunction syndrome.
    Ulldemolins M; Roberts JA; Lipman J; Rello J
    Chest; 2011 May; 139(5):1210-1220. PubMed ID: 21540219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative review.
    Ewoldt TM; Abdulla A; Hunfeld N; Li L; Smeets TJL; Gommers D; Koch BCP; Endeman H
    Expert Opin Drug Metab Toxicol; 2022 Jun; 18(6):413-421. PubMed ID: 35912845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.